Tonmya is the first new fibromyalgia treatment approved by the FDA in more than 15 years, providing symptom relief for at ...

Prefilled syringes of Imuldosa now have the lowest wholesaler acquisition cost among all branded ustekinumab biosimilars, ...

Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...

Joshua Fredell, Pharm.D., senior vice president at CVS Caremark, says innovation in PBMs comes from simplifying pricing, offering flexible benefit designs, and using technology to create a smoother ...

In an analysis from Trilliant Health of 11 inpatient and outpatient procedures, Aetna and UnitedHealthcare had huge variations in rates across the country, across states, and even at the same facility ...

An expert discusses how non-muscle invasive bladder cancer (NMIBC) is a localized form of urothelial cell carcinoma that primarily affects older men with smoking as the primary risk factor, requiring ...

An expert discusses how non-muscle invasive bladder cancer (NMIBC) creates a significant clinical and financial burden with up to 60% recurrence rates, affecting an estimated 85,000 new patients ...

We’ll be back on Monday morning with more fresh content!

Recent research confirms that aluminum in childhood vaccines does not increase the risk of autoimmune, allergic or ...

To help Medicare plans better manage members with high drug expenses, Prime Therapeutics has launched an AI-driven tool to ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive (MHE) editorial advisory board, is host of the ...

Papzimeos is the first and only FDA-approved treatment for adults with recurrent respiratory papillomatosis (RRP), with ...